Dependence on specialized expertise
The company develops technically advanced medical products that require scarce scientific and commercial skills.
- Scope
- Product development, manufacturing, commercialization
- Materiality
- high
Scandinavian ChemoTech
Scandinavian ChemoTech AB is a Swedish medical technology company based in Lund that develops tumor-specific electroporation (TSE™) systems for cancer treatment in humans and animals. Its business centers on patented treatment platforms, associated treatment kits, and clinical applications sold through the Human Care and Animal Care segments, with activity focused mainly in Sweden, India, Europe, and North America.
| % | |
|---|---|
| Animal Care treatment kits | 70% Consumable treatment kits and related veterinary oncology products used in animal cancer care. |
| Human Care oncology systems | 20% Human cancer treatment solutions and associated clinical applications, primarily for India. |
| Clinical development and validation | 5% Clinical studies, collaborations, and evidence generation supporting product adoption. |
| Regulatory and market access activities | 5% Product registration and commercialization support for new markets. |
The company sells to veterinary clinics, animal hospitals, and distributors serving animal oncology markets, especially...
- Veterinary clinics and animal hospitalsprimary
Buy Animal Care treatment kits for oncology procedures in companion animals and horses.
- Distributors and agentsprimary
Purchase and resell products into regional markets, especially where direct sales coverage is limited.
- Clinical and research partnerssecondary
Collaborate on studies, validation, and product refinement to support adoption and registration.
- Human-care providers in Indiasecondary
Buy or evaluate human oncology solutions where affordable treatment alternatives are scarce.
ChemoTech is headquartered in Lund, Sweden, and its business is organized around Nordic development and international...
- •Headquartered in Lund, Sweden
- •Human Care focus is primarily India
- •Animal Care focus spans Scandinavia and Europe
- •North America is an important Animal Care market
- •International sales depend on distributors and registrations
The company’s strategy is to commercialize its patented TSE™ platform through focused segment execution: Animal Care...
01
Expand Animal Care commercializationshort-term
Animal Care is the main revenue engine and benefits from short order-to-delivery cycles and repeat kit demand.
02
Advance Human Care market entry in Indiamedium-term
India offers a large need for cost-effective oncology solutions and could broaden the company’s addressable market.
03
Strengthen clinical evidence and partnershipsmedium-term
Clinical validation supports physician and veterinarian adoption and helps differentiate the platform.
04
Broaden geographic registrationsmedium-term
Regulatory approvals are required before sales can scale in new countries.
ChemoTech depends on specialized expertise, external distributors, and continued product validation, so execution risk...
Distributor and agent dependence
External sales channels are central to market access, so partner performance directly affects revenue.
- Scope
- International sales execution
- Materiality
- high
Regulatory approval delays
Products must be registered country by country before commercialization can scale.
- Scope
- India and other target markets
- Materiality
- high
Financing risk
Expansion, product development, and market entry require capital before cash generation is broad-based.
- Scope
- Growth funding
- Materiality
- high
Intellectual property protection
The TSE™ platform relies on patents and proprietary know-how that competitors could attempt to copy.
- Scope
- Technology differentiation
- Materiality
- high
Competition from better-capitalized medtech firms
Larger competitors could outspend the company on development, distribution, and regulatory work.
- Scope
- Niche oncology devices
- Materiality
- medium
Revenue recognition timing
Quarterly comparability
Capitalized development and intangible assets
Balance sheet and earnings
Working capital and receivables
Cash flow and liquidity
Seasonality and small-base volatility
Period-to-period comparability
Securetech Innovations, Inc.
SCTH · Motor Vehicle Parts & Accessories
Addtech
ADDT-B.ST · Industrials
Addtech is an international technical solutions group listed on the Stockholm Stock Exchange since 2001.
Pierce Group
PIERCE.ST · Consumer Discretionary
Pierce Group is a European e-commerce company specializing in the sale of motorcycle and snowmobile gear, parts, and accessories.
Cavotec Group
CCC.ST · Industrials
Cavotec Group AB is an engineering company specializing in connection and electrification solutions aimed at decarbonizing ports and industrial applications globally.
Byggmax Group
BMAX.ST · Consumer Discretionary
Byggmax Group is a prominent Nordic retail chain specializing in building materials and DIY products.
Scandi Standard
SCST.ST · Consumer Staples
Scandi Standard is a leading producer of chicken-based products in the Nordic region, focusing on both ready-to-cook and ready-to-eat segments.
: 11/08/2026